SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is a top trending stock following reports it may revise its Warner Bros. Discovery acquisition bid to an all-cash offer, a development viewed by many as a bullish signal of financial strength and deal certainty, yet others see it as a reactive move amid competitive and legal pressures. With its upcoming earnings report, the community is actively debating a potential pre-earnings rally fueled by anticipated strong fundamentals against lingering concerns over market manipulation and the broader implications of its M&A strategy for future growth.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is sparking intense debate as a Zacks Strong Buy rating and reports of robust customer asset growth are met with frustration over persistent dilution and the stock's failure to mirror broader market and crypto gains. Bulls emphasize underlying strong fundamentals and international expansion, seeing a significant valuation opportunity, while bears are vocal about continuous selling pressure and intense competition within the digital brokerage sector.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is commanding significant attention as investors await key Producer Price Index data and a pivotal Supreme Court ruling on tariffs, fueling widespread debate over market direction. Community discussions highlight recurring "V-shaped" recoveries and volatility, with broader concerns about geopolitical events and central bank independence influencing sentiment in this tech-heavy index.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is experiencing significant buzz driven by a potent combination of catalysts, including highly anticipated Japanese regulatory approval, compelling pancreatic cancer data, and its presentation at the J.P. Morgan Healthcare Conference. The community is actively highlighting this stacking of positive developments, anticipating increased institutional attention and potential index inclusions as the company's innovative alpha-radiation therapy gains wider recognition.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of America is a major talking point following a strong earnings report driven by robust net interest income, prompting several analyst upgrades and an optimistic outlook from its recent investor day. The community is actively weighing the bank's ambitious return on equity targets against broader financial sector discussions around credit health and its new strategy to recommend crypto allocations to clients.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing increased attention following strong preliminary Q4 revenue and positive 2026 guidance for its MS treatment, Briumvi, with many anticipating blockbuster status. The community is actively discussing how a recent setback for a competitor's BTK inhibitor further bolsters Briumvi's market position, alongside anticipation for its subcutaneous formulation. Despite positive fundamentals and growth, there's ongoing debate among investors regarding the stock's current valuation and the company's long-term strategy.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is experiencing heightened attention driven by its upcoming investor presentation at the J.P. Morgan Healthcare Conference, with community discussions buzzing around its significant short interest and the potential for a squeeze. Investors are keenly awaiting announcements regarding new partnerships for its Matrix-M adjuvant technology, particularly in oncology and other vaccine applications, reflecting both strong asset potential and persistent questions about management's ability to capitalize.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant upward momentum driven by promising developments across its pipeline, including a combined flu and COVID vaccine and advancements in its oncology partnership with Merck. Investors are responding positively to an improved financial outlook and regulatory progress for its next-generation COVID-19 and H5 pandemic flu vaccine candidates. The community is actively debating the stock's "undervalued" status and the potential for a substantial short squeeze, further bolstered by a broader uptrend in the biotech sector.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is actively trending as recent analyst downgrades from UBS and Wolfe Research spark heated debate, with many in the community dismissing them as manipulative tactics to shake out retail investors. Bullish sentiment remains strong, driven by high anticipation for the upcoming R2 launch and recent updates on its production validation, which many believe will be a significant catalyst for future growth. Meanwhile, bears point to ongoing losses and intense EV sector competition as fundamental concerns.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BriaCell Therapeutics (BCTX) is a major talking point after a significant public offering and issuance of warrants caused a sharp sell-off, overshadowing recent positive clinical data that showed a complete resolution of lung metastasis in a breast cancer patient. The community is deeply divided, with many long-term investors expressing frustration over a perceived "pump and dump" cycle and management's dilution practices, while others view the current dip as a potential trading opportunity in the volatile biotech space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.

Aroa Biosurgery Limited

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

AROAF
Aroa Biosurgery Limited

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AROAF News

AROAFAroa Biosurgery Limited